Nichols R L
Department of Surgery, Tulane University School of Medicine, New Orleans, Louisiana 70112.
Diagn Microbiol Infect Dis. 1989 Jul-Aug;12(4 Suppl):195S-199S. doi: 10.1016/0732-8893(89)90136-3.
Intraabdominal sepsis is frequently seen following penetrating or blunt abdominal trauma as well as with perforated appendicitis or diverticulitis. The initial leakage of endogenous gastrointestinal microflora into the peritoneal cavity results in peritonitis and secondary septicemia, which often results in a localized intraabdominal abscess. These infections are commonly polymicrobial and correlate directly with the unique endogenous microflora at various levels of the gastrointestinal tract. The successful treatment of intraabdominal sepsis is primarily associated with prompt, appropriate surgical intervention. Parenterally administered antibiotics are also required to decrease the incidence of local bacterial infection or septicemia. The choice of the appropriate agent(s) to be used initially, before obtaining the results of culture and sensitivity tests, depends primarily on both the clinical presentation and on whether the intraabdominal infection occurred in the community or as a result of hospitalization. Clinical and experimental studies of intraabdominal sepsis have primarily emphasized the use of antibiotic agents that have a spectrum of activity effective against aerobic coliforms and the anaerobe Bacteroides fragilis.
腹腔内脓毒症常见于穿透性或钝性腹部创伤后,以及阑尾穿孔或憩室炎时。内源性胃肠道微生物群最初漏入腹腔会导致腹膜炎和继发性败血症,这通常会导致局限性腹腔内脓肿。这些感染通常是多微生物的,并且与胃肠道不同水平的独特内源性微生物群直接相关。腹腔内脓毒症的成功治疗主要与及时、适当的手术干预有关。还需要胃肠外使用抗生素以降低局部细菌感染或败血症的发生率。在获得培养和药敏试验结果之前,最初选择合适的药物主要取决于临床表现以及腹腔内感染是发生在社区还是因住院引起。腹腔内脓毒症的临床和实验研究主要强调使用对需氧大肠菌和厌氧脆弱拟杆菌有效的一系列抗生素。